CASI Pharmaceuticals Interest Expense 2011-2026 | CASI

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense CASI Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.9 K	3.1 K	5.6 K	7.5 K	7.5 K	-26.1 K	-81.5 K	-26.6 K	1.66 K	10 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10 M	-81.5 K	994 K

Quarterly Interest Expense CASI Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	11 K	11 K	38 K	-	487 K	33 K	1 M	-	1.2 K	700	190 K	-	414 K	320 K	49 K	-	11 K	13.1 K	6.73 K	-	-546	-72	142	-	-5.61 K	-8.76 K	-8.77 K	-	-24.3 K	-24.3 K	-24.2 K	-	-2.93 K	129	384	-	408	443	-390	-	-	9.17 M	876 K	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.17 M	-24.3 K	392 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Adagene ADAG	1.11 M	$ 2.83	-2.75 %	$ 159 M	China
Biogen BIIB	250 M	$ 177.27	0.62 %	$ 25.8 B	USA
ANI Pharmaceuticals ANIP	-4.03 M	$ 81.19	-0.98 %	$ 1.57 B	USA
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Aytu BioScience AYTU	-512 K	$ 2.56	-0.78 %	$ 16.1 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.23	-0.92 %	$ 7.77 B	Australia
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Catalyst Biosciences CBIO	1.04 M	$ 10.0	-1.43 %	$ 658 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Cerus Corporation CERS	1.98 M	$ 2.3	-1.08 %	$ 424 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Cellectis S.A. CLLS	371 K	$ 3.81	-4.51 %	$ 116 M	France
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	65.5 M	$ 223.79	-0.07 %	$ 5 B	Danmark
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA
Atreca BCEL	3 K	-	-11.76 %	$ 5.79 M	USA
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 68.89	-0.33 %	$ 9.21 B	USA
Catalyst Pharmaceuticals CPRX	21.1 M	$ 24.53	-0.2 %	$ 2.91 B	USA
Cardiff Oncology CRDF	-39 K	$ 1.68	3.75 %	$ 80.1 M	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 4.03	-1.71 %	$ 8.77 B	Israel
Amneal Pharmaceuticals AMRX	11.8 M	$ 13.77	-2.45 %	$ 4.25 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA